Patent details

EP1682536 Title: PROCESS FOR THE MANUFACTURE OF THE CALCIUM SALT OF ROSUVASTATIN (E)-7-Ö4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-ÖMETHYL(METHYLSULFONYL)AMINOÜ PYRIMIDIN-5-YLÜ(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND CRYSTALLINE INTERMEDIATES THEREOF

Basic Information

Publication number:
EP1682536
PCT Application Number:
PCT/GB/2004/004481
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047689971
PCT Publication Number:
WO/2005/042522
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PROCESS FOR THE MANUFACTURE OF THE CALCIUM SALT OF ROSUVASTATIN (E)-7-Ö4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-ÖMETHYL(METHYLSULFONYL)AMINOÜ PYRIMIDIN-5-YLÜ(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND CRYSTALLINE INTERMEDIATES THEREOF
French Title of Invention:
PROCEDE DE FABRICATION DU SEL DE CALCIUM DE L'ACIDE ROSUVASTATINE - (E)-7-Ö4- (4-FLUOROPHENYL)-6-ISOPROPYL-2- ÖMETHYL(METHYLSULFONYL)AMINO ÜPYRIMIDIN-5-YLÜ (3R,5S)-3, 5-DIHYDROXYHEPT-6-ENOIQUE ET DE SES INTERMEDIAIRES CRISTALLINS
German Title of Invention:
VERFAHREN ZUR HERSTELLUNG DES CALCIUMSALZES VON ROSUVASTATIN-(E)-7-Ö4-(4-FLUORPHENYL)-6-ISOPROPYL-2-ÖMETHYL(METHYLSULFONYL)AMINOÜ PYRIMIDIN-5-YLÜ(3R,5S)-3,5-DIHYDROXYHEPT-6-ENSÄURE- UND KRISTALLINEN ZWISCHENPRODUKTEN DAVON
SPC Number:

Dates

Filing date:
22/10/2004
Grant date:
27/02/2013
EP Publication Date:
27/02/2013
PCT Publication Date:
12/05/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/07/2006
EP B1 Publication Date:
27/02/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/10/2013
Expiration date:
22/10/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/10/2004
 
 

Name:
AstraZeneca UK Limited
Address:
2 Kingdom Street, London W2 6BD, United Kingdom (GB)

Name:
SHIONOGI & CO. LTD.
Address:
1-8, Doshomachi 3-chome, Chuo-ku, Osaka 541-0045, Japan (JP)

Inventor

1

Name:
OKADA Tetsuo, Shionogi & Company Limited
Address:
Japan (JP)

2

Name:
LAFFAN David Dermot Patrick, AstraZeneca
Address:
United Kingdom (GB)

3

Name:
HORBURY John, AstraZeneca
Address:
United Kingdom (GB)

Priority

Priority Number:
0324791
Priority Date:
24/10/2003
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 405/06;

Publication

European Patent Bulletin

Issue number:
201949
Publication date:
04/12/2019
Description:
Opposition rejected; Patent maintained as granted
Filing date Document type Number of pages